Insiders who reported open-market trades in the last 12 months at the companies Peter Heerma files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
William E. Rote - $14.02M in TVTX purchases and sales in the last 12 months
Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
Peter Heerma is a corporate insider, tracked as EVP, CHIEF COMMERCIAL OFFICER of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter Heerma submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter Heerma been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($18.77M) across all tracked filings.
Peter Heerma is EVP, CHIEF COMMERCIAL OFFICER of Travere Therapeutics, Inc. (TVTX). 7 SEC Form 4 filings on record going back to 2025, most recently on 18 September 2026. Most recent open-market trade: sold $539K of TVTX on 18 September 2026. Lifetime open-market sales: $18.77M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Peter Heerma.
InsiderAlpha's records for Peter Heerma go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. 24 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
